EMA Excellence in Pharmacovigilance: Clinical Trials and Post-marketing Training, London, 17-21 February 2014
Feb 17, 2014
Dr Jan Petracek CEO of PharmInvent will give a series of lectures at the 5-day training course presented by the European Medicines Agency and organized by DIA in London.
The training course is designed to provide a solid understanding of the key aspects of Global Clinical Pre and Post Marketing Safety. The program will include highlights and updates regarding the implementation of the new pharmacovigilance legislation as well as the latest news on the international harmonisation and standardisation activities regarding pharmacovigilance.
The training course will take place at the European Medicines Agency in London on 17-21 February 2014. For a detailed agenda and for course registration please view the attached program or contact DIA.